{"schema_version":"secwatch.filing_event.v1","accession":"0000055529-22-000020","form_type":"8-K","ticker":"KEQU","cik":"0000055529","company_name":"KEWAUNEE SCIENTIFIC CORP /DE/","filed_at":"2022-12-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.242508+00:00","generated_at":"2026-06-21T07:48:19.804422+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Kewaunee Scientific Q2 sales up 39.8% to $54.6M; net loss narrows to $0.09/share from $1.11","bullets":["Sales $54.6M (+39.8% YoY); pre-tax earnings $456k vs loss $2.9M; net loss $243k vs $3.1M.","Diluted loss per share $0.09 vs $1.11; EBITDA $1.25M vs ($2.12M).","Domestic segment sales $38.0M (+26.9%); international segment $16.6M (+82.2%).","Backlog $157.8M (up from $139.7M YoY); cash $16.3M (vs $6.9M); no short-term debt.","CEO says improvement despite legacy direct contracts; continuing shift to dealer partners."],"urls":{"canonical":"https://secwatch.observer/filing/0000055529-22-000020","json":"https://secwatch.observer/filing/0000055529-22-000020.json","markdown":"https://secwatch.observer/filing/0000055529-22-000020.md","text":"https://secwatch.observer/filing/0000055529-22-000020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/55529/000005552922000020/0000055529-22-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/55529/000005552922000020/kequ-20221207.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T07:48:19.804422+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3cbcb94d69b4baf9fe1252506f92e54ca880bdd3","claim":"KEWAUNEE SCIENTIFIC CORP /DE/ reported the second quarter ended October 31, 2022 results: revenue $54,564,000, net income a net loss of $243,000, EPS ($0.09) per diluted share.","evidence_excerpt":"Sales during the second quarter of fiscal year 2023 were $54,564,000, an increase of 39.8% compared to sales of $39,031,000 from the prior year second quarter. Pre-tax earnings for the quarter were $456,000 compared to a pre-tax loss of $2,887,000 for the prior year period. Kewaunee recorded a net loss of $243,000 compared to net loss of $3,100,000 for the prior year period.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/55529/000005552922000020/0000055529-22-000020-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the second quarter ended October 31, 2022"},{"label":"Revenue","value":"$54,564,000"},{"label":"Net income","value":"a net loss of $243,000"},{"label":"EPS","value":"($0.09) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}